Germany – Pharmaceutical products – Abschluss einer nicht-exklusiven Rabattvereinbarung nach § 130a Absatz 8 SGB V zum W
DAK-Gesundheit awarded a contract of undisclosed value to 1 A Pharma GmbH for Healthcare & Medical in September 2025 — one of 389 awards this buyer has made.
Buying agency
DAK-GesundheitWinning supplier
1 A Pharma GmbHContract description
Germany – Pharmaceutical products – Abschluss einer nicht-exklusiven Rabattvereinbarung nach § 130a Absatz 8 SGB V zum Wirkstoff Timolol + Brinzolamid, ATC S01ED67 für die Zeit 01.11.2024 - 31.10.2026
Related awards · DAK-Gesundheit
389 awardsThe buyer's full award list ranked by value, with the winning supplier, date and sector on every row — plus CSV / API export.
- ocds-ted-210283-2024Aktivital GmbH€9.1M10 Apr 2024 Healthcare
- ocds-ted-211590-2024Kraaibeek GmbH€2.5M10 Apr 2024 Healthcare
- ocds-ted-828775-2025news aktuell GmbH€38.0K12 Dec 2025 IT
Other wins · 1 A Pharma GmbH
18 winsThe supplier's complete win history across every buyer it sells to — not just the handful shown here.
- ocds-ted-210038-2025-3AOK Baden-Württemberg Hauptverwaltung€221K02 Apr 2025 Healthcare
- ocds-ted-767498-2024-3AOK Baden-Württemberg Hauptverwaltung€221K16 Dec 2024 Healthcare
- ocds-ted-93145-2025-1AOK Baden-Württemberg Hauptverwaltung€221K11 Feb 2025 Healthcare
Premium · full dataset
See the full award context.
Competing bids, award margins and every related contract for DAK-Gesundheit and 1 A Pharma GmbH — one subscription unlocks everything.
Sign Up Free →Free account · cancel anytime · 14-day money-back